{
  "trial_id": "NCT03597360",
  "overall_assessment": "likely_eligible",
  "inclusion": [
    {
      "criterion": "severe AD dementia",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "AD (NIA-AA)",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "acetylcholinesterase inhibitors and/or memantine",
      "label": "met",
      "evidence": "unknown"
    },
    {
      "criterion": "clinically stable for at least 3 months",
      "label": "met",
      "evidence": "unknown"
    }
  ],
  "exclusion": [
    {
      "criterion": "Current or past history of malignancy",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Previous history of radiotherapy",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Neurological disorder other than AD",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "Currently receiving other experimental treatments",
      "label": "not_met",
      "evidence": "none"
    },
    {
      "criterion": "Clinical or imaging evidence of stroke (with more than 1-2 lacunar infarcts on CT scan or MRI)",
      "label": "unknown",
      "evidence": "quote"
    },
    {
      "criterion": "Major depression, bipolar affective disorder or psychosis",
      "label": "not_met",
      "evidence": "none"
    }
  ],
  "notes": "16-year-old girl with myasthenia gravis, class IIa. She has diplopia and weakness affecting her upper extremities despite treatment.",
  "_meta": {
    "topic_id": "72",
    "trial_id": "NCT03597360",
    "model": "llama3.1:8b",
    "run_tag": "llama31_8b_full_top100",
    "top_k": 100
  }
}